Fitch Rates Indian Pharma As "Stable" For 2010 But Will Be Concerned Over Large Debt-led Capital Expenditure Plans
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - For 2010, the Indian pharmaceutical market will continue to expand aided by a sales growth of 11-12 percent, as more and more people see a rise in their purchasing power and health insurance spreads out more prominently, indicated Fitch Ratings - known for its credit risk rating analysis - in its outlook report for the Indian pharmaceutical industry
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)